STOCKSCOUTER
StockScouter Premium
StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance
Learn more or Get it now! Stockscouter Portfolio performance
KURA KURA ONCOLOGY INCORPORATED StockScouter® Report
9
StockScouter® Score
KURA ONCOLOGY INCORPORATED, a small cap company in the healthcare sector, is expected to outperform the market over the next six months with average risk
10 is the best possible rating. Learn more.
Summary
Positives
- The multi-period measure of relative price change and consistency is well above average. Positive
- Moving average analysis for KURA suggests strong price movement over the medium term. Positive
- Shares are under accumulation by financial institutions. Marginally positive for a small company like KURA
Concerns
- One or more analysts has modestly decreased quarterly earnings estimates for KURA. Negative
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that small cap stocks will be neutral, stocks will be , and healthcare stocks will be neutral.
Expected Risk/Return
Core Model Grades
C
C
N/A
A